Syncona Says Beacon Therapeutics Reports Positive Topline in Vista Trial
Syncona said Beacon Therapeutics delivered a positive topline result in its Phase II/III Vista trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.